Evidence map›Paper›PMID 40083359›Full record

ArticleJournal of medical imaging (Bellingham, Wash.)2025

HID-CON: weakly supervised intrahepatic cholangiocarcinoma subtype classification of whole slide images using contrastive hidden class detection.

Jing Wei Tan, Kyoungbun Lee, Won-Ki Jeong

Abstract read
In one paragraph

Article in Journal of medical imaging (Bellingham, Wash.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jing Wei TanKorea University, College of Informatics, Department of Computer Science and Engineering, Seoul, Republic of Korea.
Kyoungbun LeeSeoul National University Hospital, Department of Pathology, Seoul, Republic of Korea.ORCID https://orcid.org/0000-0001-8427-3003
Won-Ki JeongKorea University, College of Informatics, Department of Computer Science and Engineering, Seoul, Republic of Korea.ORCID https://orcid.org/0000-0002-9393-6451

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Biliary tract cancer, also known as intrahepatic cholangiocarcinoma (IHCC), is a rare disease that shows no clear symptoms during its early stage, but its prognosis depends highly on the cancer subtype. Hence, an accurate cancer subtype classification model is necessary to provide better treatment plans to patients and to reduce mortality. However, annotating histopathology images at the pixel or patch level is time-consuming and labor-intensive for giga-pixel whole slide images. To address this problem, we propose a weakly supervised method for classifying IHCC subtypes using only image-level labels. Approach: The core idea of the proposed method is to detect regions (i.e., subimages or patches) commonly included in all subtypes, which we name the "hidden class," and to remove them via iterative application of contrastive loss and label smoothing. Doing so will enable us to obtain only patches that faithfully represent each subtype, which are then used to train the image-level classification model by multiple instance learning (MIL). Results: Our method outperforms the state-of-the-art weakly supervised learning methods ABMIL, TransMIL, and DTFD-MIL by Conclusions: The introduction of a hidden class to represent patches commonly found across all subtypes enhances the accuracy of IHCC classification and addresses the weak labeling problem in histopathology images.

Indexed as

contrastive learningintrahepatic cholangiocarcinomamultiple instance learningweakly supervised learning

Identifiers

PMID40083359
PMCPMC11898109

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.